Bibliography
- Zanger UM , RaimundoS, EichelbaumM: Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry.Naunyn-Schmiedeberg‘s Arch. Pharmacol.369 , 23–37 (2004).
- Ingelman-Sundberg M , SimSC, GomezA, Rodriguez-AntonaC: Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.Pharmacol. Ther.116 , 496–526 (2007).
- Zanger UM , TurpeinenM, KleinK, SchwabM: Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation.Anal. Bioanal. Chem.392 , 1093–1108 (2008).
- Sistonen J , SajantilaA, LaoO, CoranderJ, BarbujaniG, FuselliS: CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure.Pharmacogenet. Genomics17 , 93–101 (2007).
- Gaedigk A , NdjountchéL, DivakaranK et al.: Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity: characterization of gene duplication events.Clin. Pharmacol. Ther.81 , 242–251 (2007).
- Gaedigk A , BradfordLD, AlanderSW, LeederJS: CYP2D6*36 gene arrangements within the CYP2D6 locus: association of CYP2D6*36 with poor metabolizer status.Drug Metab. Dispos.34 , 563–569 (2006).
- Panserat S , MuraC, GerardN et al.: An unequal cross-over event within the CYP2D gene cluster generates a chimeric CYP2D7/CYP2D6 gene which is associated with the poor metabolizer phenotype.Br. J. Clin. Pharmacol.40 , 361–367 (1995).
- Daly AK , FairbrotherKS, AndreassenOA, LondonSJ, IdleJR, SteenVM: Characterization and PCR-based detection of two different hybrid CYP2D7P/CYP2D6 alleles associated with the poor metabolizer phenotype.Pharmacogenetics6 , 319–328 (1996).
- Gaedigk A , GotschallRR, ForbesNS, SimonSD, KearnsGL, LeederJS: Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data.Pharmacogenetics9 , 669–682 (1999).
- Gaedigk A , CoetseeC: The CYP2D6 gene locus in South African Coloureds: unique allele distributions, novel alleles and gene arrangements.Eur. J. Clin. Pharmacol.64 , 465–475 (2008).
- Gaedigk A , SimonSD, PearceRE, BradfordLD, KennedyMJ, LeederJS: The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype.Clin. Pharmacol. Ther.83 , 234–242 (2008).
- Leathart JBS , LondonSJ, StewardA, AdamsJD, IdleJR, DalyAK: CYP2D6 phenotype –genotype relationships in African–Americans and Caucasians in Los Angeles.Pharmacogenetics8 , 529–541 (1998).
- Dover GA : Molecular drive in multigene families: how biological novelties arise, spread and are assimilated.Trends Genet.2 , 159–165 (1986).
- Hastings PJ , LupskiJR, RosenbergSM, IraG: Mechanisms of change in gene copy number.Nat. Rev. Genet.10 , 551–564 (2009).
- Lundqvist E , JohanssonI, Ingelman-SundbergM: Genetic mechanism for duplication and multiduplication of the CYP2D6 gene.Gene226 , 327–338 (1999).
- L⊘vlie R , DalyAK, MolvenA, IdleJR, SteenVM: Ultrarapid metabolizers of debrisoquine: Characterization and PCR-based detection of alleles with duplication of the CYP2D6 gene.FEBS Letters392 , 30–34 (1996).
- Steen VM , MolvenA, AarskogNK, GulbrandsenAK: Homologous unequal cross-over involving a 2.8 kb direct repeat as a mechanism for the generation of allelic variants of the cytochrome P450 CYP2D6 gene.Hum. Mol. Genet.4 , 2251–2257 (1995).
- Johansson I , OscarsonM, Q-YueY, BertilssonL, SjöqvistF, Ingelman-SundbergM: Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes in subjects with diminished capacity for debrisoquine hydroxylation.Mol. Pharmacol.46 , 452–459 (1994).
- Hanioka N , OkumuraY, SaitoY et al.: Catalytic roles of CYP2D6.10 and CYP2D6.36 enzymes in mexiletine metabolism: In vitro functional analysis of recombinant proteins expressed in Saccharomyces cervisiae.Biochem. Pharmacol.71 , 1386–1395 (2006).
- Koren G , CairnsJ, ChitayatD, GaedigkA, LeederSJ: Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother.Lancet368 , 704 (2006).
- Madadi P , RossCJR, HaydenMR et al.: Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case–control study.Clin. Pharmacol. Ther.85 , 31–35 (2009).
- Madadi P , KorenG: Pharmacogenetic insights into codeine analgesia: implications to pediatric codeine use.Pharmacogenomics9 , 1267–1284 (2008).
▪ Website
- Home Page of the Human Cytochrome P450 (CYP) Allele Nomenclature Committee www.cypalleles.ki.se/ (Accessed 07April2009)